Matricelf Ltd. Logo

Matricelf Ltd.

Develops autologous, patient-specific tissue implants for regenerative medicine.

MTLF | TA

Overview

Corporate Details

ISIN(s):
IL0011767915
LEI:
Country:
Israel
Address:
3 Golda Meir Street, 7651713 Ness Zion

Description

Matricelf Ltd. is a preclinical-stage biotechnology company specializing in regenerative medicine and tissue engineering. The company develops a proprietary platform for creating fully autologous, patient-specific tissue implants. This technology combines a patient's induced Pluripotent Stem Cells (iPSCs) with a personalized, thermo-responsive hydrogel derived from their own extracellular matrix (ECM). The iPSCs are differentiated within this hydrogel to generate functional tissue. This autologous approach is designed to minimize the risk of immune rejection and provide a personalized, curative therapy. Matricelf's primary focus is on developing a one-time treatment for spinal cord injuries, aiming to bridge damaged tissue and restore lost function. The platform is also being explored for other conditions, including stroke, traumatic brain injury, and myocardial infarction.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-09-08 20:40
COMPANY'S PRESENTATION
Hebrew (modern) 2.3 MB
2024-09-08 20:40
COMPANY'S PRESENTATION
Russian 42.8 KB
2024-03-27 15:30
INVESTORS PRESENTATION
English 2.7 MB
2024-03-27 15:30
INVESTORS PRESENTATION
Russian 43.3 KB
2023-02-14 16:31
Corporate Presentation - February2023
English 1.1 MB
2023-02-14 16:31
Corporate Presentation - February2023
Russian 42.7 KB
2022-03-16 10:59
INVESTORS PRESENTATION
English 2.7 MB
2022-03-16 10:59
INVESTORS PRESENTATION
Russian 41.6 KB
2021-06-17 18:14
Opening of Trading On Sunday June 20, 2021, Appointment of a Market Maker
Hebrew (modern) 256.5 KB
2021-06-14 14:20
Identifying Details of New Security: MATRICELF, MATRICELF.W1
Hebrew (modern) 177.2 KB

Automate Your Workflow. Get a real-time feed of all Matricelf Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Matricelf Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Matricelf Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Stayble Therapeutics AB Logo
Develops treatments for chronic pain originating from spinal disc conditions.
Sweden
STABL
STCUBE Logo
Develops immuno-oncology therapies targeting novel immune checkpoints for cancer.
South Korea
052020
StemRIM Inc. Logo
Develops regenerative medicine that uses the body's own stem cells for tissue repair.
Japan
4599
Surrozen, Inc./DE Logo
Develops drug candidates to selectively modulate the Wnt pathway for tissue repair.
United States of America
SRZN
SyntekaBio,Inc. Logo
An AI-driven drug discovery company using supercomputing to accelerate development.
South Korea
226330
Tango Therapeutics, Inc. Logo
A clinical-stage biotech developing precision oncology medicines via synthetic lethality.
United States of America
TNGX
Taysha Gene Therapies, Inc. Logo
Clinical-stage company developing AAV-based gene therapies for severe CNS diseases.
United States of America
TSHA
Tectonic Therapeutic, Inc. Logo
Clinical-stage biotech developing biologics targeting G-Protein Coupled Receptors (GPCRs).
United States of America
TECX
Telomir Pharmaceuticals, Inc. Logo
Pre-clinical pharma company developing a small molecule for aging and chronic disease.
United States of America
TELO
Tempest Therapeutics, Inc. Logo
Clinical-stage oncology company developing small molecule and cell therapies for cancer.
United States of America
TPST

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.